Document Detail

New advances in the treatment of atrial fibrillation: focus on stroke prevention.
MedLine Citation:
PMID:  25112657     Owner:  NLM     Status:  Publisher    
Introduction: Atrial fibrillation (AF) is the most common arrhythmia and brings about significant mortality and morbidity as a result of heart failure and ischemic stroke. Besides vitamin K antagonists (VKA), several new pharmacological agents (nonvitamin K antagonist oral anticoagulants [NOACs]) and procedures have since been developed to improve stroke prevention efforts in AF. Areas covered: This paper will discuss the antiplatelet agents, VKA and NOACs, and their efficacy and safety for stroke prevention in AF. Focus will be placed on the NOACs, their limitations and special considerations. A short assessment of other nonpharmacological antithrombotic procedures will also be made. An extensive PubMed search was used to identify suitable papers. Expert opinion: Despite the advent of NOACs, the VKAs will remain as an important oral anticoagulant due to its versatility. However, convenience and limited food or drug interactions will make NOACs attractive options. The choice between various NOACs will depend on several important factors as illustrated below. Over time, the role for antiplatelet agents will gradually diminish. Left atrial appendage occlusion devices have shown promising results and may have the potential to change the way clinicians manage thromboembolism risks related to AF.
Yee C Lau; Gregory Yh Lip
Related Documents :
6864987 - The failure of oxygen breathing to decrease the myocardial contractile force in denerva...
7258087 - Protective effect of chronic versus acute cardiac denervation on contractile force duri...
24775217 - Hypoxemia and stroke in a patient with a pacemaker.
23667497 - Impact of scotland's comprehensive, smoke-free legislation on stroke.
11028497 - Coronary echocardiography in tetralogy of fallot: diagnostic accuracy, resource utiliza...
10155097 - Ptca using the right radial artery access site.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-12
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  -     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-12     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Geriatric Emergency Department Innovations: Preliminary Data for the Geriatric Nurse Liaison Model.
Next Document:  Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-gra...